Expedited approval of cancer drugs without randomized controlled trials: Too good to be true?

Daniel Shepshelovich, Eitan Amir

Research output: Contribution to journalEditorial

Original languageEnglish
Pages (from-to)30942-30943
Number of pages2
JournalOncotarget
Volume9
Issue number57
DOIs
StatePublished - 24 Jul 2018
Externally publishedYes

Keywords

  • Cancer
  • Expedited approval
  • FDA
  • Randomized controlled trials
  • Safety

Cite this